Trial intelligence / Profile preview

Dexmedetomidine and Postoperative Sleep Quality in Perimenopausal Women Undergoing Laparoscopic Surgery

ChiCTR2500114562Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Dalian Medical University
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine in sleep disorder (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Pittsburgh Sleep Quality Index (PSQI) score. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2500114562.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500114562.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call